mRNA |
GW-405833 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.6 |
mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
BCL-LZH-4 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.6 |
mRNA |
lapatinib |
FIMM |
pan-cancer |
AAC |
-0.076 |
0.6 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |